Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection.
Vigón L, Rodríguez-Mora S, Luna A, Sandonís V, Mateos E, Bautista G, Steegmann JL, Climent N, Plana M, Pérez-Romero P, de Ory F, Alcamí J, García-Gutierrez V, Planelles V, López-Huertas MR, Coiras M. Vigón L, et al. Among authors: sandonis v. Biochem Pharmacol. 2020 Dec;182:114203. doi: 10.1016/j.bcp.2020.114203. Epub 2020 Aug 20. Biochem Pharmacol. 2020. PMID: 32828803 Free PMC article.
Circulatory follicular helper T lymphocytes associate with lower incidence of CMV infection in kidney transplant recipients.
Suàrez-Fernández P, Utrero-Rico A, Sandonis V, García-Ríos E, Arroyo-Sánchez D, Fernández-Ruiz M, Andrés A, Polanco N, González-Cuadrado C, Almendro-Vázquez P, Pérez-Romero P, Aguado JM, Paz-Artal E, Laguna-Goya R. Suàrez-Fernández P, et al. Among authors: sandonis v. Am J Transplant. 2021 Dec;21(12):3946-3957. doi: 10.1111/ajt.16725. Epub 2021 Jul 16. Am J Transplant. 2021. PMID: 34153157 Free article.
Post-transplant dynamics and clinical significance of CMV-specific neutralizing antibodies in kidney transplant recipients treated with T-cell-depleting agents.
Fernández-Ruiz M, García-Ríos E, Redondo N, Rodríguez-Goncer I, Ruiz-Merlo T, Parra P, Sandonis V, López-Medrano F, San Juan R, González E, Polanco N, Andrés A, Navarro D, Aguado JM, Pérez-Romero P. Fernández-Ruiz M, et al. Among authors: sandonis v. J Infect Dis. 2023 Sep 22:jiad411. doi: 10.1093/infdis/jiad411. Online ahead of print. J Infect Dis. 2023. PMID: 37740549
COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
Mazagatos C, Delgado-Sanz C, Monge S, Pozo F, Oliva J, Sandonis V, Gandarillas A, Quiñones-Rubio C, Ruiz-Sopeña C, Gallardo-García V, Basile L, Barranco-Boada MI, Hidalgo-Pardo O, Vazquez-Cancela O, García-Vázquez M, Fernández-Sierra A, Milagro-Beamonte A, Ordobás M, Martínez-Ochoa E, Fernández-Arribas S, Lorusso N, Martínez A, García-Fulgueiras A, Sastre-Palou B, Losada-Castillo I, Martínez-Cuenca S, Rodríguez-Del Águila M, Latorre M, Larrauri A; SARI surveillance VE group in Spain. Mazagatos C, et al. Among authors: sandonis v. Influenza Other Respir Viruses. 2022 Nov;16(6):1014-1025. doi: 10.1111/irv.13026. Epub 2022 Jul 26. Influenza Other Respir Viruses. 2022. PMID: 35880469 Free PMC article.
Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.
Pernas M, Casado C, Sandonis V, Arcones C, Rodríguez C, Ruiz-Mateos E, Ramírez de Arellano E, Rallón N, Del Val M, Grau E, López-Vazquez M, Leal M, Del Romero J, López Galíndez C. Pernas M, et al. Among authors: sandonis v. J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):225-31. doi: 10.1097/QAI.0b013e31829bdc85. J Acquir Immune Defic Syndr. 2013. PMID: 23714744
15 results